Literature DB >> 20684013

Inheritance and variable expression in Rubinstein-Taybi syndrome.

Oliver Bartsch1, Wolfram Kress, Olga Kempf, Stanislav Lechno, Thomas Haaf, Ulrich Zechner.   

Abstract

Familial Rubinstein-Taybi syndrome (RTS) is very rare. Here we report on the 6th and 7th case of inherited RTS. Family 1 presents with incomplete or mild RTS over three generations; a 13-year-old girl (proband 1) with mild but typical facial features and learning disabilities, her very mildly affected mother (proband 2), and the maternal grandmother (proband 3). Family 2 includes three females with classical RTS (probands 4-6) and their father (proband 7) with broad thumbs and halluces. Proband 5 also had a brain tumor (ganglioglioma) at the age of 3 years. In probands 1-3, direct sequencing identified a novel CREBBP missense mutation, c.2728A > G (predicting p.Thr910Ala), that was absent in non-affected family members. The p.Thr910Ala variant is outside the crucial histone acetyltransferase domain, and this may explain the mild and variable phenotype. In probands 4-7 we identified another novel CREBBP mutation, c.4134G > T, which alters the consensus splice sequence at position 1 of exon 25. The c.4134G > T mutation was transmitted from the very mildly affected father who displayed somatic mosaicism (with 38% mutated alleles in blood and 31% in buccal smear DNA) to his three daughters. Our findings emphasize that variable expression (family 1) and somatic mosaicism (family 2) contribute to the phenotypic variability of RTS. Somatic mosaicism may be more frequent in RTS than previously assumed. Accumulating data suggest a recurrence risk of approximately 0.5-1% for parents of a child with RTS, exceeding the so far estimated risk of approximately 0.1% for siblings. Copyright 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20684013     DOI: 10.1002/ajmg.a.33598

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  18 in total

Review 1.  The role of histone acetylation in memory formation and cognitive impairments.

Authors:  Lucia Peixoto; Ted Abel
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

2.  Expressional and mutational analysis of CREBBP gene in gastric and colorectal cancers with microsatellite instability.

Authors:  Min Sung Kim; Nam Jin Yoo; Sug Hyung Lee
Journal:  Pathol Oncol Res       Date:  2013-07-10       Impact factor: 3.201

3.  Phenotype comparison confirms ZMYND11 as a critical gene for 10p15.3 microdeletion syndrome.

Authors:  Birute Tumiene; Ž Čiuladaitė; E Preikšaitienė; R Mameniškienė; A Utkus; V Kučinskas
Journal:  J Appl Genet       Date:  2017-09-21       Impact factor: 3.240

4.  Mosaic CREBBP mutation causes overlapping clinical features of Rubinstein-Taybi and Filippi syndromes.

Authors:  Tamar I de Vries; Glen R Monroe; Martine J van Belzen; Christian A van der Lans; Sanne Mc Savelberg; William G Newman; Gijs van Haaften; Rutger A Nievelstein; Mieke M van Haelst
Journal:  Eur J Hum Genet       Date:  2016-03-09       Impact factor: 4.246

Review 5.  Ultra-Rare Syndromes: The Example of Rubinstein-Taybi Syndrome.

Authors:  Silvia Spena; Cristina Gervasini; Donatella Milani
Journal:  J Pediatr Genet       Date:  2015-09-28

Review 6.  The clinical relevance of neuroplasticity in corticostriatal networks during operant learning.

Authors:  Matthew E Andrzejewski; Brenda L McKee; Anne E Baldwin; Lindsay Burns; Pepe Hernandez
Journal:  Neurosci Biobehav Rev       Date:  2013-04-05       Impact factor: 8.989

Review 7.  Rubinstein-Taybi syndrome: clinical features, genetic basis, diagnosis, and management.

Authors:  Donatella Milani; Francesca Maria Paola Manzoni; Lidia Pezzani; Paola Ajmone; Cristina Gervasini; Francesca Menni; Susanna Esposito
Journal:  Ital J Pediatr       Date:  2015-01-20       Impact factor: 2.638

8.  CREBBP is a target of epigenetic, but not genetic, modification in juvenile myelomonocytic leukemia.

Authors:  Christoph Plass; Christian Flotho; Silvia Fluhr; Melanie Boerries; Hauke Busch; Aikaterini Symeonidi; Tania Witte; Daniel B Lipka; Oliver Mücke; Peter Nöllke; Christopher Felix Krombholz; Charlotte M Niemeyer
Journal:  Clin Epigenetics       Date:  2016-05-05       Impact factor: 6.551

9.  CREBBP and EP300 mutational spectrum and clinical presentations in a cohort of Swedish patients with Rubinstein-Taybi syndrome.

Authors:  Josephine Wincent; Aron Luthman; Martine van Belzen; Christian van der Lans; Johanna Albert; Ann Nordgren; Britt-Marie Anderlid
Journal:  Mol Genet Genomic Med       Date:  2015-09-22       Impact factor: 2.183

10.  First case report of inherited Rubinstein-Taybi syndrome associated with a novel EP300 variant.

Authors:  María López; Verónica Seidel; Paula Santibáñez; Cristina Cervera-Acedo; Pedro Castro-de Castro; Elena Domínguez-Garrido
Journal:  BMC Med Genet       Date:  2016-12-13       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.